Company news
Zhejiang Chengyi Pharmaceutical Co. Ltd. news in 2026
Zhejiang Chengyi Pharmaceutical Co. Ltd.'s news releases, calls and decks from 2026, newest first.
(603811)"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Report for Q3 2026
October 28, 2026
(603811)"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Key Operating Data for Q3 2026
October 28, 2026
(603811)"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Results of Shareholding Reduction by Director and Senior Executive
October 22, 2026
Announcement on Results of Shareholding Reduction by Senior Executive
September 30, 2026
Announcement on a Subsidiary's Receipt of Drug GMP Compliance Inspection Results
September 28, 2026
Announcement on Outline of the 2026 Semi-annual Performance Briefing
September 17, 2026
Announcement on Satisfaction of Unlocking Conditions for the 1st Unlocking Period under the 2025 Employee Stock Ownership Plan
September 15, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
September 10, 2026
Announcement on Resolutions of the 6th Meeting of the 5th Board of Directors
August 26, 2026
Announcement on Shareholding Reduction Plan for Directors and Senior Management Members
June 30, 2026
Announcement on Progress in Providing Guarantee for Subsidiary
June 22, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 18, 2026
Announcement on Results of GMP Compliance Inspection Concerning Drugs
June 4, 2026
Announcement on Outline of the Performance Briefing for 2025 and Q1 2026
May 22, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
May 19, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 14, 2026
Announcement on Remunerations for Directors and Senior Management Members in 2025 and 2026 Remuneration Plan
April 23, 2026
Announcement on Selection of Products for Continuation Procurement Under National Procurement Scheme After Agreement Expiry
February 10, 2026